Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 15/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3547170 | 0.89 | PIN1 (0.44) | PIN1MAPTALDH1A1 | |
| SCHEMBL14941629 | 0.84 | PIN1 (0.44) | PIN1MAPTL3MBTL1ALDH1A1 | |
| SCHEMBL14941630 | 0.84 | PIN1 (0.44) | PIN1MAPTL3MBTL1ALDH1A1 | |
| SCHEMBL1204074 | 0.83 | PIN1 (0.43) | PIN1MAPTALDH1A1 | |
| SCHEMBL4087952 | 0.80 | PIN1 (0.35) | PIN1MAPTL3MBTL1ALDH1A1RAB9A | |
| SCHEMBL4085806 | 0.77 | KMT2A (0.38) | PIN1MAPTL3MBTL1ALDH1A1 | |
| SCHEMBL3547171 | 0.77 | PIN1 (0.45) | PIN1MAPTL3MBTL1ALDH1A1 | |
| SCHEMBL4084432 | 0.76 | CTSB (0.33) | PIN1MAPTALDH1A1 | |
| SCHEMBL3674116 | 0.76 | PDE4B (0.33) | PIN1MAPTALDH1A1 | |
| SCHEMBL4077793 | 0.76 | PIN1 (0.47) | PIN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7517873-B2 | Substituted pyrimidodiazepines | HOFFMAN-LA ROCHE INC. (US) | 2009-04-14 | — | — | US | disclosed |
| US-20080234255-A1 | SUBSTITUTED PYRIMIDODIAZEPINES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234255-A1 | SUBSTITUTED PYRIMIDODIAZEPINES | PLK1, CCNI, CDK1 | PIN1 792/4885MAPT 2296/4885L3MBTL1 2166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.